Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

APTUS PHARMA LTD.

NSE : NABSE : 544529ISIN CODE : INE15XJ01010Industry : TradingHouse : Private

BSE129.5119.18 (+17.38 %)

PREV CLOSE ( ) 110.33

OPEN PRICE ( ) 113.98

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 150000

TODAY'S LOW / HIGH ( )112.00 132.39

52 WK LOW / HIGH ( ) 80.8132.39

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-08 2010

Management Info

- Chairman Tejash Maheshchandra Hathi - Managing Director

Registered Office

Address Ashutosh Buildcon, Opp. Slok - 2,Nr. Harikrupa Logistic Park,Aslali, Daskroi,
Ahmedabad,
Gujarat-382427

Phone 7600427827

Email info@aptuspharma.com

Website www.aptus-pharma.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE

NEWS

17Oct Clarification sought from Aptus Pharm
The Exchange has sought clarification from Aptus Pharma Ltd on October 1..

29Sep New Listing
Notice No. 20250929-80 Notice Date 29 Sep 2025Category Company r..

22Sep Aptus Pharma coming with IPO to raise
Aptus PharmaAptus Pharma is coming out with an initial public offering (..

Financials

Rs. in Millions

	QTR	ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Parshva Enterprises (BSE) 324.40 (19.99%)	M.Cap ( in Cr)330.56
India Motor Parts (BSE) 1078.15 (2.55%)	M.Cap ( in Cr)1345.53
Emergent Ind Soln (BSE) 558.05 (5.00%)	M.Cap ( in Cr)254.97
SK Minerals & Add (BSE) 152.25 (19.88%)	M.Cap ( in Cr)186.35
RRP Defense (BSE) 761.25 (2.00%)	M.Cap ( in Cr)1044.34

Shareholding Pattern

	PROMOTERS	72.89%
	NON-INSTITUTION	14.29%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

APTUS PHARMA LTD.